Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $386.11 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ethicon Inc. | $141.26 | 1 | $0 (2019) |
| Genentech USA, Inc. | $81.34 | 6 | $0 (2022) |
| ARBOR PHARMACEUTICALS, INC. | $67.26 | 5 | $0 (2018) |
| Mission Pharmacal Company | $33.40 | 2 | $0 (2017) |
| Merck Sharp & Dohme LLC | $32.16 | 2 | $0 (2022) |
| Nabriva Therapeutics, plc | $16.85 | 1 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $13.84 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $34.10 | 2 | Merck Sharp & Dohme LLC ($21.00) |
| 2021 | $11.48 | 1 | Genentech USA, Inc. ($11.48) |
| 2020 | $59.90 | 4 | Genentech USA, Inc. ($29.21) |
| 2019 | $168.30 | 3 | Ethicon Inc. ($141.26) |
| 2018 | $78.93 | 6 | ARBOR PHARMACEUTICALS, INC. ($67.26) |
| 2017 | $33.40 | 2 | Mission Pharmacal Company ($33.40) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Virology & Specialty Care | ||||||
| 01/06/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Virology & Specialty Care | ||||||
| 11/12/2020 | Nabriva Therapeutics, plc | Sivextro (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Oxazolidinone antibiotics | ||||||
| 11/12/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Central Nervous System | ||||||
| 03/05/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Virology & Specialty Care | ||||||
| 01/16/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Virology & Specialty Care | ||||||
| 12/03/2019 | Ethicon Inc. | MONARCH (Device) | Food and Beverage | In-kind items and services | $141.26 | General |
| Category: ENDO-MECHANICAL | ||||||
| 11/22/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Virology & Specialty Care | ||||||
| 07/01/2019 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), SIVEXTRO, DULERA | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Pediatrics/Neonatology | ||||||
| 11/14/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Virology & Specialty Care | ||||||
| 10/04/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Pediatrics/Neonatology | ||||||
| 08/02/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Pediatrics/Neonatology | ||||||
| 05/10/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Pediatrics/Neonatology | ||||||
| 01/23/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Pediatrics/Neonatology | ||||||
| 04/01/2017 | Mission Pharmacal Company | Hycofenix (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Oral antitussive, nasal decongestant and expectorant | ||||||
| 02/17/2017 | Mission Pharmacal Company | Hycofenix (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Oral antitussive, nasal decongestant and expectorant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 162 | 188 | $27,583 | $7,931 |
| 2021 | 10 | 382 | 449 | $69,117 | $28,377 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 81 | $12,879 | $3,759 | 29.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 38 | 46 | $7,250 | $1,995 | 27.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 28 | $2,800 | $985.04 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,520 | $639.94 | 25.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 20 | 22 | $2,134 | $552.66 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 128 | $20,352 | $9,220 | 45.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 80 | 106 | $16,854 | $7,512 | 44.6% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 65 | 72 | $7,200 | $2,544 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 24 | $5,640 | $2,406 | 42.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $7,552 | $2,353 | 31.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,949 | $1,512 | 38.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 20 | 21 | $3,400 | $1,078 | 31.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 21 | 25 | $2,425 | $1,039 | 42.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 14 | 17 | $1,615 | $669.63 | 41.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 13 | $130.00 | $45.24 | 34.8% |
About Dr. Mathew Thomas, MD
Dr. Mathew Thomas, MD is a Internal Medicine healthcare provider based in Plainville, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568543429.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mathew Thomas, MD has received a total of $386.11 in payments from pharmaceutical and medical device companies, with $34.10 received in 2022. These payments were reported across 18 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($386.11).
As a Medicare-enrolled provider, Thomas has provided services to 544 Medicare beneficiaries, totaling 637 services with total Medicare billing of $36,308. Data is available for 2 years (2021–2022), covering 15 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Plainville, CT
- Active Since 10/18/2006
- Last Updated 10/19/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568543429
Products in Payments
- MONARCH (Device) $141.26
- Xofluza (Drug) $81.34
- Otovel (Drug) $67.26
- Hycofenix (Drug) $33.40
- BELSOMRA (Drug) $21.00
- Sivextro (Drug) $16.85
- AJOVY (Biological) $13.84
- ASMANEX (Drug) $11.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Plainville
Krishna Gunturu, Mbbs, MBBS
Internal Medicine — Payments: $25,027
Dr. Owen Debowy, Md Phd, MD PHD
Internal Medicine — Payments: $2,943
Oosman Tariq
Internal Medicine — Payments: $2,801
Papa Badoe, Md, MD
Internal Medicine — Payments: $2,153
Doris Altherr, Md, MD
Internal Medicine — Payments: $831.38
Dr. Stephen Zebrowski, M.d, M.D
Internal Medicine — Payments: $661.65